Elizaveta A. Naumova
Elizaveta A. Naumova has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Alfiya R. Tyapayeva
V. I. Razumovsky Saratov State Medical University
6 shared publications - O. N. Semenova
V. I. Razumovsky Saratov State Medical University
6 shared publications - Aleksandra Aleksandrovna Boroday
Saratov State Medical University named after V. I. Razumovsky
2 shared publications - Dariya Andreevna Tyapkina
Saratov State Medical University named after V. I. Razumovsky
2 shared publications - Yulia V. Bulaeva
V.I. Razumovsky Saratov State Medical University
2 shared publications A D Trubetskoĭ
1 shared publication
Latest Publications
- Open Access
- 28 February 2024
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 29 (1S) , 5605
Medication adherence of cardiovascular patients after COVID-19: 6-month follow-up
Aim. To evaluate the relationship of various factors with adherence to therapy in cardiovascular patients after a coronavirus disease 2019 (COVID-19).Material and methods. The study included 284 patients (inpatients — 176, outpatients — 108) with cardiovascular diseases (hypertension, heart failure (HF), coronary artery disease, atrial fibrillation) after COVID-19. We collected data on cardiovascular history, made a questionnaire survey about COVID-19 course (symptoms, their severity, self-assessment of the disease severity). Paraclinical diagnostic investigations were carried out. In addition, 1, 3, 6 months after recovery, all respondents were invited for examination, laboratory tests, and survey using the Hospital Anxiety and Depression Scale (HADS). Cardiovascular therapy adherence was assessed at 1, 3 and 6 months after recovery and adherence to COVID-19 treatment 1 month after inclusion in the study by comparing the compliance of the drugs prescribed at discharge with its actual use.Results. In total, 212 respondents continued study participation after 1 month, while 64,2% were adherent to cardiovascular therapy and 56,6% — to COVID-19 therapy. Compliance at 3 and 6 months was 60,4% (n=212) and 52,8% (n=188), respectively. A moderate correlation was found between adherence to treatment and the persistence of apprehension 1 month after recovery (r=0,33, p<0,05), moderate or severe weakness during disease (r=0,31, p<0,05), COVID-19 severity (r=0,39, p25% (n=64, 36,4%) were more adherent to standard cardiovascular therapy, prescribed in accordance with clinical guidelines (r=0,336, p<0,05). Adverse events in the form of a hypertensive crisis, arrhythmias, decompensated HF 1, 3, 6 months after recovery significantly increased the compliance with medical recommendations (p<0,05). Medication adherence regarding COVID-19 was associated with the disease severity, HF history, apprehension and anxiety, weakness, and decreased exercise tolerance (p0,05). Compliance after 1, 3, 6 months was positively influenced by COVID-19 severity, the subjective feeling of weakness, apprehension and anxiety during disease and the persistence of a subjective feeling of anxiety after recovery. Adverse events (hypertensive crisis, arrhythmia, decompensated HF) during 1, 3 and 6 months after COVID-19 significantly (p<0,05) increased adherence to treatment.
- 28 February 2024
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 29 (1S) , 5605
Open AccessMedication adherence of cardiovascular patients after COVID-19: 6-month follow-up
Aim. To evaluate the relationship of various factors with adherence to therapy in cardiovascular patients after a coronavirus disease 2019 (COVID-19).Material and methods. The study included 284 patients (inpatients — 176, outpatients — 108) with cardiovascular diseases (hypertension, heart failure (HF), coronary artery disease, atrial fibrillation) after COVID-19. We collected data on cardiovascular history, made a questionnaire survey about COVID-19 course (symptoms, their severity, self-assessment of the disease severity). Paraclinical diagnostic investigations were carried out. In addition, 1, 3, 6 months after recovery, all respondents were invited for examination, laboratory tests, and survey using the Hospital Anxiety and Depression Scale (HADS). Cardiovascular therapy adherence was assessed at 1, 3 and 6 months after recovery and adherence to COVID-19 treatment 1 month after inclusion in the study by comparing the compliance of the drugs prescribed at discharge with its actual use.Results. In total, 212 respondents continued study participation after 1 month, while 64,2% were adherent to cardiovascular therapy and 56,6% — to COVID-19 therapy. Compliance at 3 and 6 months was 60,4% (n=212) and 52,8% (n=188), respectively. A moderate correlation was found between adherence to treatment and the persistence of apprehension 1 month after recovery (r=0,33, p<0,05), moderate or severe weakness during disease (r=0,31, p<0,05), COVID-19 severity (r=0,39, p25% (n=64, 36,4%) were more adherent to standard cardiovascular therapy, prescribed in accordance with clinical guidelines (r=0,336, p<0,05). Adverse events in the form of a hypertensive crisis, arrhythmias, decompensated HF 1, 3, 6 months after recovery significantly increased the compliance with medical recommendations (p<0,05). Medication adherence regarding COVID-19 was associated with the disease severity, HF history, apprehension and anxiety, weakness, and decreased exercise tolerance (p0,05). Compliance after 1, 3, 6 months was positively influenced by COVID-19 severity, the subjective feeling of weakness, apprehension and anxiety during disease and the persistence of a subjective feeling of anxiety after recovery. Adverse events (hypertensive crisis, arrhythmia, decompensated HF) during 1, 3 and 6 months after COVID-19 significantly (p<0,05) increased adherence to treatment.
- Open Access
- 25 December 2023
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 12 (4) , 209-219
COVID-19 IN PATIENTS WITH CARDIOVASCULAR DISEASES AND WITHOUT CARDIOVASCULAR PATHOLOGY: RESULTS OF THE INTERNET SURVEY
Highlights According to the results of an online survey, the prevalence of COVID-19 is not associated with cardiovascular pathology, however, respondents in the group with cardiovascular diseases suffer significantly more often and more severely. Cardiovascular diseases have no impact on the level of vaccination and the incidence of post-vaccination reactions. AbstractAim. To study the prevalence of COVID-19 and the clinical features of the disease among Internet users with and without cardiovascular pathology.Methods. An anonymous online survey was conducted among users of various social networks using a questionnaire created with the help of the SurveyMonkey platform. The survey was conducted in December 2021 – January 2022, it lasted 1 month and included 23 questions regarding the clinical and demographic characteristics of respondents, the presence of cardiovascular diseases (CVD), the incidence of COVID-19, the features of clinical manifestations of the disease, the severity of the course among respondents with and without cardiovascular pathology, the need for medical care, vaccinations.Results. 752 respondents took part in the survey: 627 participants without cardiovascular pathology and 125 with CVD. More than 50.0% (51.5 vs 62.4%) of the two groups surveyed had COVID-19 (p = 0.2). 42.5% of participants without CVD and 50.7% of people with CVD had COVID-19 in the period from September 2020 to April 2021 (2nd wave in Russia). Among the groups with and without CVD, 79.2% of individuals had coronavirus infection confirmed by any of the diagnostic methods: polymerase chain reaction (48.8% vs 50.0%), radiography (2.4% vs 2.9%), the presence of antibodies to IgG/IgM (15.1% vs 15.7%), contact with an infected person (9.8% vs 2.9%), p = 0.09. Most often, patients without CVD noted: fever, impaired sense of smell and taste, whereas participants with CVD noted: weakness, cough, shortness of breath, anxiety, depression, blood pressure destabilization. The lung lesion volume in respondents without CVD in 37.8% of cases was less than 25%, and in 43.2% of people with CVD – 25–50% (p = 0.03). Most of the patients in both groups (52.6% vs 40.6%) sought medical help at the polyclinic, the rest (39.1% vs 37.7%) resorted to self-medication. More than 65.0% of the surveyed of both groups were vaccinated against COVID-19, and more than 35.0% of them reported adverse events.Conclusion. In respondents without CVD, the disease was more often of mild severity, and in people with CVD – of moderate severity. In participants with CVD, the lung lesion volume was more often 25–50%. All respondents noted both the complete disappearance of clinical manifestations of the disease immediately after recovery, and the long-term persistence of symptoms (up to a year). More than 35.0% of respondents preferred to self-medicate. Patients with CVD were more often hospitalized due to the severity of the disease. More than 65.0% of the survey participants of the two groups were vaccinated, and about 35.0% of them reported side effects.
- 25 December 2023
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 12 (4) , 209-219
Open AccessCOVID-19 IN PATIENTS WITH CARDIOVASCULAR DISEASES AND WITHOUT CARDIOVASCULAR PATHOLOGY: RESULTS OF THE INTERNET SURVEY
Highlights According to the results of an online survey, the prevalence of COVID-19 is not associated with cardiovascular pathology, however, respondents in the group with cardiovascular diseases suffer significantly more often and more severely. Cardiovascular diseases have no impact on the level of vaccination and the incidence of post-vaccination reactions. AbstractAim. To study the prevalence of COVID-19 and the clinical features of the disease among Internet users with and without cardiovascular pathology.Methods. An anonymous online survey was conducted among users of various social networks using a questionnaire created with the help of the SurveyMonkey platform. The survey was conducted in December 2021 – January 2022, it lasted 1 month and included 23 questions regarding the clinical and demographic characteristics of respondents, the presence of cardiovascular diseases (CVD), the incidence of COVID-19, the features of clinical manifestations of the disease, the severity of the course among respondents with and without cardiovascular pathology, the need for medical care, vaccinations.Results. 752 respondents took part in the survey: 627 participants without cardiovascular pathology and 125 with CVD. More than 50.0% (51.5 vs 62.4%) of the two groups surveyed had COVID-19 (p = 0.2). 42.5% of participants without CVD and 50.7% of people with CVD had COVID-19 in the period from September 2020 to April 2021 (2nd wave in Russia). Among the groups with and without CVD, 79.2% of individuals had coronavirus infection confirmed by any of the diagnostic methods: polymerase chain reaction (48.8% vs 50.0%), radiography (2.4% vs 2.9%), the presence of antibodies to IgG/IgM (15.1% vs 15.7%), contact with an infected person (9.8% vs 2.9%), p = 0.09. Most often, patients without CVD noted: fever, impaired sense of smell and taste, whereas participants with CVD noted: weakness, cough, shortness of breath, anxiety, depression, blood pressure destabilization. The lung lesion volume in respondents without CVD in 37.8% of cases was less than 25%, and in 43.2% of people with CVD – 25–50% (p = 0.03). Most of the patients in both groups (52.6% vs 40.6%) sought medical help at the polyclinic, the rest (39.1% vs 37.7%) resorted to self-medication. More than 65.0% of the surveyed of both groups were vaccinated against COVID-19, and more than 35.0% of them reported adverse events.Conclusion. In respondents without CVD, the disease was more often of mild severity, and in people with CVD – of moderate severity. In participants with CVD, the lung lesion volume was more often 25–50%. All respondents noted both the complete disappearance of clinical manifestations of the disease immediately after recovery, and the long-term persistence of symptoms (up to a year). More than 35.0% of respondents preferred to self-medicate. Patients with CVD were more often hospitalized due to the severity of the disease. More than 65.0% of the survey participants of the two groups were vaccinated, and about 35.0% of them reported side effects.
- 1 January 2023
- Published by Geotar-Media Publishing Group in Infectious diseases: News, Opinions, Training
- Vol. 12 (1)
Online survey results among social network users in terms of the COVID-19 problem
Результаты интернет-опроса пользователей социальных сетей по проблеме COVID-19
- 1 January 2023
- Published by Geotar-Media Publishing Group in Infectious diseases: News, Opinions, Training
- Vol. 12 (1)
Online survey results among social network users in terms of the COVID-19 problem
Результаты интернет-опроса пользователей социальных сетей по проблеме COVID-19
- 31 March 2022
- Published by Ryazan State Medical University in Nauka Molodykh (Eruditio Juvenium)
- Vol. 10 (1)
Manifestations of a New Coronavirus Infection in Patients with Cardiovascular Diseases Undergoing Outpatient Treatment
BACKGROUND: SARS-CoV-2 virus, which induces COVID-19, not only affects the lungs, but also negatively affects the cardiovascular system, causing decompensation of the existing cardiovascular diseases (CVD). AIM: Тo find out the peculiarities of the course and treatment of the new coronavirus infection COVID-19 in patients with cardiovascular diseases (CVD). MATERIALS AND METHODS: A survey was conducted among patients with CVD undergoing outpatient treatment for COVID-19. A special questionnaire was developed containing 48 questions about the symptoms of COVID-19 and the prescribed therapy. The respondents were ill with a new coronavirus infection between August 2020 and January 2021. The survey involved 54 patients aged 43–82 years, among them 36 (66.7%) women and 18 (33.3%) men. Patients of age groups 61–70 years and 51–60 years prevailed (33.3% and 29.6%, respectively). The respondents had the following CVD: arterial hypertension — 54 (100%) and coronary heart disease (exertion angina) — 16 (29.6%). RESULTS. COVID-19 was manifested by cough — in 32 (59.3%) patients, shortness of breath — in 34 (63%). There was marked weakness (44 (81.5%)), limitation of physical activity (48 (88.9%)). Of the skin manifestations, patients described itching (14 (25.9%)). Myalgia was present in 40 (74.1%) patients and joint pain — in 36 (66.7%). Of the classic manifestations of COVID-19 infection, 34 (40.7%) and 22 (50%) patients had reduction or loss of olfaction and gustatory sensations. On the part of the gastrointestinal tract, the following symptoms were present: lack of appetite (6 (11.1%)), nausea (6 (11.1%)) and diarrhea (2 (3.7%)). Neurological manifestations of COVID-19, such as episodes of dizziness, disorientation in space and time, and feelings of fear and anxiety, were observed in 38 (70.6%) respondents. There were also unusual manifestations of the disease: increased blood pressure, decreased blood pressure, weakness in the legs, disorders in urination, ring-shaped granuloma, conjunctivitis, tickling in throat. Treatment: most patients with mild and moderate course of the disease took drugs that are not specified in the recommendations of the Ministry of Health of the Russian Federation for COVID-19. CONCLUSIONS: The majority of patients with CVD had manifestations of COVID-19 on the part of the respiratory, musculoskeletal systems, as well as neurological manifestations of the disease. Skin manifestations and manifestations on the part of the gastrointestinal tract were present only in a small part of the respondents.
- 31 March 2022
- Published by Ryazan State Medical University in Nauka Molodykh (Eruditio Juvenium)
- Vol. 10 (1)
Manifestations of a New Coronavirus Infection in Patients with Cardiovascular Diseases Undergoing Outpatient Treatment
BACKGROUND: SARS-CoV-2 virus, which induces COVID-19, not only affects the lungs, but also negatively affects the cardiovascular system, causing decompensation of the existing cardiovascular diseases (CVD). AIM: Тo find out the peculiarities of the course and treatment of the new coronavirus infection COVID-19 in patients with cardiovascular diseases (CVD). MATERIALS AND METHODS: A survey was conducted among patients with CVD undergoing outpatient treatment for COVID-19. A special questionnaire was developed containing 48 questions about the symptoms of COVID-19 and the prescribed therapy. The respondents were ill with a new coronavirus infection between August 2020 and January 2021. The survey involved 54 patients aged 43–82 years, among them 36 (66.7%) women and 18 (33.3%) men. Patients of age groups 61–70 years and 51–60 years prevailed (33.3% and 29.6%, respectively). The respondents had the following CVD: arterial hypertension — 54 (100%) and coronary heart disease (exertion angina) — 16 (29.6%). RESULTS. COVID-19 was manifested by cough — in 32 (59.3%) patients, shortness of breath — in 34 (63%). There was marked weakness (44 (81.5%)), limitation of physical activity (48 (88.9%)). Of the skin manifestations, patients described itching (14 (25.9%)). Myalgia was present in 40 (74.1%) patients and joint pain — in 36 (66.7%). Of the classic manifestations of COVID-19 infection, 34 (40.7%) and 22 (50%) patients had reduction or loss of olfaction and gustatory sensations. On the part of the gastrointestinal tract, the following symptoms were present: lack of appetite (6 (11.1%)), nausea (6 (11.1%)) and diarrhea (2 (3.7%)). Neurological manifestations of COVID-19, such as episodes of dizziness, disorientation in space and time, and feelings of fear and anxiety, were observed in 38 (70.6%) respondents. There were also unusual manifestations of the disease: increased blood pressure, decreased blood pressure, weakness in the legs, disorders in urination, ring-shaped granuloma, conjunctivitis, tickling in throat. Treatment: most patients with mild and moderate course of the disease took drugs that are not specified in the recommendations of the Ministry of Health of the Russian Federation for COVID-19. CONCLUSIONS: The majority of patients with CVD had manifestations of COVID-19 on the part of the respiratory, musculoskeletal systems, as well as neurological manifestations of the disease. Skin manifestations and manifestations on the part of the gastrointestinal tract were present only in a small part of the respondents.
- Open Access
- 3 November 2021
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 17 (5) , 683-687
A Randomized Open Clinical Study of the Atherosclerosis Treatment Information Video Effect on Adherence to Long-Term Therapy in Patients with Cardiovascular Diseases
Aim. Study the effect of a study video, which was created by researchers and devoted to the atherosclerosis development and the effect of statin therapy on atherosclerotic plaque, on adherence to long-term therapy in patients with high or very high risk of cardiovascular complications.Material and methods. 120 patients admitted to hospital with cardiovascular diseases were included in the study. Patients were randomized into 2 groups: in the main group (n=60), the information video edited by the researchers was shown to patients on the eve of discharge, in addition to a printed brochure on lifestyle and diet modification, and in the control group (n=60), patients were given only a standard brochure. The motivating video shows the damage to the cardiovascular system by the atherosclerotic process and the beneficial effect on the body of constant intake of statins. After 1 and 3 months after discharge from the hospital, telephone calls were made, after which the patients had to visit the center for an objective examination by a researcher and control of laboratory parameters. After 1 month, 110 patients visited the center, after 3 months, 98 respondents visited the center.Results. The group with the information video demonstration noted more frequent adherence to medical recommendations compared to the control: after 1 month, 52 (96%) patients continued treatment versus 48 (86%) patients, 3 months after discharge 48 (96%) patients continued treatment versus 38 (79%) patients (pConclusion. Demonstration of a motivating video about the effect of statins on the atherosclerosis course increases patient adherence to medicinal therapy, including adherence to statins.
- 3 November 2021
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 17 (5) , 683-687
Open AccessA Randomized Open Clinical Study of the Atherosclerosis Treatment Information Video Effect on Adherence to Long-Term Therapy in Patients with Cardiovascular Diseases
Aim. Study the effect of a study video, which was created by researchers and devoted to the atherosclerosis development and the effect of statin therapy on atherosclerotic plaque, on adherence to long-term therapy in patients with high or very high risk of cardiovascular complications.Material and methods. 120 patients admitted to hospital with cardiovascular diseases were included in the study. Patients were randomized into 2 groups: in the main group (n=60), the information video edited by the researchers was shown to patients on the eve of discharge, in addition to a printed brochure on lifestyle and diet modification, and in the control group (n=60), patients were given only a standard brochure. The motivating video shows the damage to the cardiovascular system by the atherosclerotic process and the beneficial effect on the body of constant intake of statins. After 1 and 3 months after discharge from the hospital, telephone calls were made, after which the patients had to visit the center for an objective examination by a researcher and control of laboratory parameters. After 1 month, 110 patients visited the center, after 3 months, 98 respondents visited the center.Results. The group with the information video demonstration noted more frequent adherence to medical recommendations compared to the control: after 1 month, 52 (96%) patients continued treatment versus 48 (86%) patients, 3 months after discharge 48 (96%) patients continued treatment versus 38 (79%) patients (pConclusion. Demonstration of a motivating video about the effect of statins on the atherosclerosis course increases patient adherence to medicinal therapy, including adherence to statins.
- Open Access
- 25 October 2021
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 26 (4S) , 4603
Clinical, laboratory and psychological aspects of moderate COVID-19 in cardiovascular patients one month after discharge from the hospital
Aim. To study clinical, laboratory and psychological aspects of moderate coronavirus disease 2019 (COVID-19) in cardiovascular patients one month after discharge from the hospital.Material and methods. The study included 88 patients with cardiovascular diseases hospitalized for COVID-19. After 1 month, 72 respondents continued the participation in the study. Medical history collection, physical examination, and diagnostic investigations were performed. We used the Hospital Anxiety and Depression Scale (HADS) by Zigmond A. S., Snaith R. P., Beck Anxiety Inventory scale, Mini-mental State Examination (MMSE) scale for assessing mental status.Results. One month after discharge, there was a decrease in the number of patients with signs of impaired respiratory system, such as cough, shortness of breath, chest congestion, while a decrease in exercise tolerance persists was revealed in 80,5% (out of 95,5% during hospiatalization), generalized weakness and increased sweating — in 69,5%. In addition, 38,9% of patients noted a noticeable, newly reported, hair loss. Attention is drawn to the high prevalence of neurological symptoms during hospiatalization, including dizziness, severe headaches not relieved by analgesics and non-steroidal anti-inflammatory drugs, lethargy, disorientation of place and time, and in some cases even hallucinations. Some of the symptoms persist after 1 month: 55,5% note a decrease in memory, 36% — feelings of fear and anxiety, 63,9% — sleep disorders in the form of frequent nocturnal awakenings (19,4%), insomnia (16,6%), long falling asleep (11,1%). Some of the respondents revealed unfavorable events over the past month as follows: blood pressure (BP) destabilization in the form of episodes of BP increase and decrease during the day — 36,0%, hypertensive crisis — 14,0%. There was an increase in the number of patients with subclinical and clinical depression (pConclusion. One month after discharge, the respiratory symptoms naturally decrease, but new symptoms appear, such as shortness of breath during exercise, fatigue, unsteady gait, hair loss, and increased sweating. There was an increase in the number of patients with subclinical and clinical depression on the HADS scale. Among laboratory parameters, an increase in the number of patients with increased level of total cholesterol and low-density lipoproteins was revealed.
- 25 October 2021
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 26 (4S) , 4603
Open AccessClinical, laboratory and psychological aspects of moderate COVID-19 in cardiovascular patients one month after discharge from the hospital
Aim. To study clinical, laboratory and psychological aspects of moderate coronavirus disease 2019 (COVID-19) in cardiovascular patients one month after discharge from the hospital.Material and methods. The study included 88 patients with cardiovascular diseases hospitalized for COVID-19. After 1 month, 72 respondents continued the participation in the study. Medical history collection, physical examination, and diagnostic investigations were performed. We used the Hospital Anxiety and Depression Scale (HADS) by Zigmond A. S., Snaith R. P., Beck Anxiety Inventory scale, Mini-mental State Examination (MMSE) scale for assessing mental status.Results. One month after discharge, there was a decrease in the number of patients with signs of impaired respiratory system, such as cough, shortness of breath, chest congestion, while a decrease in exercise tolerance persists was revealed in 80,5% (out of 95,5% during hospiatalization), generalized weakness and increased sweating — in 69,5%. In addition, 38,9% of patients noted a noticeable, newly reported, hair loss. Attention is drawn to the high prevalence of neurological symptoms during hospiatalization, including dizziness, severe headaches not relieved by analgesics and non-steroidal anti-inflammatory drugs, lethargy, disorientation of place and time, and in some cases even hallucinations. Some of the symptoms persist after 1 month: 55,5% note a decrease in memory, 36% — feelings of fear and anxiety, 63,9% — sleep disorders in the form of frequent nocturnal awakenings (19,4%), insomnia (16,6%), long falling asleep (11,1%). Some of the respondents revealed unfavorable events over the past month as follows: blood pressure (BP) destabilization in the form of episodes of BP increase and decrease during the day — 36,0%, hypertensive crisis — 14,0%. There was an increase in the number of patients with subclinical and clinical depression (pConclusion. One month after discharge, the respiratory symptoms naturally decrease, but new symptoms appear, such as shortness of breath during exercise, fatigue, unsteady gait, hair loss, and increased sweating. There was an increase in the number of patients with subclinical and clinical depression on the HADS scale. Among laboratory parameters, an increase in the number of patients with increased level of total cholesterol and low-density lipoproteins was revealed.
- Open Access
- 1 December 2019
- Published by Moscow State University of Civil Engineering in Vestnik MGSU
- Vol. 14 (12) , 1555-1571
Heat engineering properties of energy-efficient material based on plant additives (dried hogweed)
Introduction. The articlecompares the heat engineering properties of construction materials: high-strength concrete, ordinary concrete, and two concrete samples containing a vegetable additive, dried stem fragments of hogweed (Heracleum sosnowskyi). The first sample contains the additive in the crushed form, while the second contains the additive in the form of tubes. The research to estimate heat conduction in the four samples under unsteady conditions. Materials and methods. The thermal diffusivity of two samples with plant additive is determined using a comparative physical experiment. When determining the thermal properties, the accumulating component of the enclosure is taken into account what leads to a long delay in the temperature variation over time. DS18B20 digital temperature sensors connected to an Arduino Uno board were used to measure the temperature. The experiment was carried out in the Challenge 250 chamber at an initial temperature of 20 ºС. Then the chamber temperature was lowered to 0 ºС within 30 minutes. In the next period, the temperature dropped from 0 ºС to –10 ºС. The data obtained are of interest for improving the energy efficiency of buildings. Results. The experiments showed that the tubular-hogweed sample is close to high-strength concrete by its heat engineering properties. The material thermal diffusivity affects the amplitude of temperature fluctuations and the accumulating capacity of the wall. Conclusions. It is established experimentally that at lower thermal diffusivity of a hogweed-containing sample, the amplitude of temperature fluctuations increases. This indicates a greater time lag, just as in the case of a high-strength concrete sample. When using the hogweed as an additive, we obtain a heat-resistant minimum-cost material for enclosures. Considering an issue of the energy efficiency in construction and existing additives to concrete, the researchers have reached the conclusion that it is efficient to use the dried hogweed as the plant additive.
- 1 December 2019
- Published by Moscow State University of Civil Engineering in Vestnik MGSU
- Vol. 14 (12) , 1555-1571
Open AccessHeat engineering properties of energy-efficient material based on plant additives (dried hogweed)
Introduction. The articlecompares the heat engineering properties of construction materials: high-strength concrete, ordinary concrete, and two concrete samples containing a vegetable additive, dried stem fragments of hogweed (Heracleum sosnowskyi). The first sample contains the additive in the crushed form, while the second contains the additive in the form of tubes. The research to estimate heat conduction in the four samples under unsteady conditions. Materials and methods. The thermal diffusivity of two samples with plant additive is determined using a comparative physical experiment. When determining the thermal properties, the accumulating component of the enclosure is taken into account what leads to a long delay in the temperature variation over time. DS18B20 digital temperature sensors connected to an Arduino Uno board were used to measure the temperature. The experiment was carried out in the Challenge 250 chamber at an initial temperature of 20 ºС. Then the chamber temperature was lowered to 0 ºС within 30 minutes. In the next period, the temperature dropped from 0 ºС to –10 ºС. The data obtained are of interest for improving the energy efficiency of buildings. Results. The experiments showed that the tubular-hogweed sample is close to high-strength concrete by its heat engineering properties. The material thermal diffusivity affects the amplitude of temperature fluctuations and the accumulating capacity of the wall. Conclusions. It is established experimentally that at lower thermal diffusivity of a hogweed-containing sample, the amplitude of temperature fluctuations increases. This indicates a greater time lag, just as in the case of a high-strength concrete sample. When using the hogweed as an additive, we obtain a heat-resistant minimum-cost material for enclosures. Considering an issue of the energy efficiency in construction and existing additives to concrete, the researchers have reached the conclusion that it is efficient to use the dried hogweed as the plant additive.
- Open Access
- 1 January 2018
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 14 (3) , 337-343
Study of Adherence to Drug Therapy of Patients with Cardiovascular Diseases in District Hospital of Small Town in Saratov Region and in Cardiology Department of University Clinic in Saratov
Aim. To study the relation of various factors with adherence to long-term drug therapy in patients with cardiovascular diseases in district hospital of small town in Saratov Region and patients from clinical hospital of Saratov medical university. Material and methods. The hospitalized patients with cardiovascular diseases were included into the prospective study of long-term adherence to treatment. Questioning of patients with the determination of the attitude of respondents to their health, the desire to receive information about the disease, the level of awareness of the therapy, the degree of participation in the treatment process, the nature of the relationship with the attending physician was performed. A year after discharge, control calls were made to patients to learn whether the patient was continuing treatment prescribed a year ago in the hospital. The data on patient adherence in both hospitals were analyzed. Results. 108 patients in the district hospital (58% of selected patients) and 70 in the Saratov hospital (33% of selected patients) responded to all questions in the questionnaire during hospitalization. Successful reaching by phone 12 months after discharge from the hospital took place in 74 patients of the small town and 40 patients of the regional center. The continuation of treatment was found in 28 (38%) and 24 (50%) patients, respectively. Patients who continued treatment significantly differed from those, who stopped therapy, by presence of myocardial infarction in anamnesis [14 (78%) patients in the university hospital and 6 (60%) patients in the district hospital; p<0.01] as well as acute cerebrovascular accident [6 (78%) patients in the university hospital and 4 (75%) patients in the district hospital; p<0.05] and stable angina class I-III [22 (61%) patients in Saratov and 28 (44%) patients in the small town; p<0.01]. Adherence to recommendations after 12 months was found in patients who considered that doctor or relatives were responsible for their health (6 patients in Saratov and 12 - in the small town; p<0.05) and believed that attending physician determines the portion of information provided to the patient [20 (60%) patients of the district hospital and 11 (63%) patients in the university clinic; p<0.05 for university clinic]. Conclusion. The adherence to long-term treatment after discharge remained low and did not exceed 50% among patients in both groups. The paternalistic model continued to dominate in the doctor-patient interconnection system.
- 1 January 2018
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 14 (3) , 337-343
Open AccessStudy of Adherence to Drug Therapy of Patients with Cardiovascular Diseases in District Hospital of Small Town in Saratov Region and in Cardiology Department of University Clinic in Saratov
Aim. To study the relation of various factors with adherence to long-term drug therapy in patients with cardiovascular diseases in district hospital of small town in Saratov Region and patients from clinical hospital of Saratov medical university. Material and methods. The hospitalized patients with cardiovascular diseases were included into the prospective study of long-term adherence to treatment. Questioning of patients with the determination of the attitude of respondents to their health, the desire to receive information about the disease, the level of awareness of the therapy, the degree of participation in the treatment process, the nature of the relationship with the attending physician was performed. A year after discharge, control calls were made to patients to learn whether the patient was continuing treatment prescribed a year ago in the hospital. The data on patient adherence in both hospitals were analyzed. Results. 108 patients in the district hospital (58% of selected patients) and 70 in the Saratov hospital (33% of selected patients) responded to all questions in the questionnaire during hospitalization. Successful reaching by phone 12 months after discharge from the hospital took place in 74 patients of the small town and 40 patients of the regional center. The continuation of treatment was found in 28 (38%) and 24 (50%) patients, respectively. Patients who continued treatment significantly differed from those, who stopped therapy, by presence of myocardial infarction in anamnesis [14 (78%) patients in the university hospital and 6 (60%) patients in the district hospital; p<0.01] as well as acute cerebrovascular accident [6 (78%) patients in the university hospital and 4 (75%) patients in the district hospital; p<0.05] and stable angina class I-III [22 (61%) patients in Saratov and 28 (44%) patients in the small town; p<0.01]. Adherence to recommendations after 12 months was found in patients who considered that doctor or relatives were responsible for their health (6 patients in Saratov and 12 - in the small town; p<0.05) and believed that attending physician determines the portion of information provided to the patient [20 (60%) patients of the district hospital and 11 (63%) patients in the university clinic; p<0.05 for university clinic]. Conclusion. The adherence to long-term treatment after discharge remained low and did not exceed 50% among patients in both groups. The paternalistic model continued to dominate in the doctor-patient interconnection system.
- Open Access
- 1 January 2012
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 8 (1) , 45-50
COMPLIANCE TO LONG-TERM TREATMENT OF CARDIOLOGIC PATIENTS WITH MILD TO MODERATE DEPRESSION: INEFFECTIVENESS OF ANTIDEPRESSIVE THERAPY WITH PIRLINDOL IN RANDOMIZED STUDY
Aim. To evaluate the influence of antidepressant therapy with pirlindol on compliance to the long-term treatment and quality of life in patients with cardiovascular diseases and mild to moderate depression. Material and methods. 61 patients with cardiovascular diseases and mild to moderate depression (according to Beck depression scale) were randomized into two groups. Patients of intervention group received pirlindol, while patients of control group did not receive this drug. Compliance to cardiovascular and antidepressant treatment were estimated in 3 and 6 months. Adverse reactions and patients self-assessment of their well-being and global satisfaction in treatmen were also registered. Results. 24 (75%), 2 (6%) and 0 patients of intervention group continue pirlindol treatment in 1, 3 and 6 months, respectively. In 3 months of observation patients of intervention group took drugs for cardiovascular diseases more often than these in control group (81% vs 72%, respectively , р<0.05), they also less frequently showed adverse reactions (56% vs 72%, respectively ,p=0.01) and more often — improvement of their well-being (65% vs 50%, respectively , р=0.03). Compliance to cardiovascular therapy did not differ significantly in patients of both groups by the end the study. Conclusion. Antidepressant therapy with pirlindol did not influence compliance to long-term cardiovascular treatment in patients with cardiovascular diseases and mild to moderate depression, apparently because of low compliance to pirlindol therapy.
- 1 January 2012
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 8 (1) , 45-50
Open AccessCOMPLIANCE TO LONG-TERM TREATMENT OF CARDIOLOGIC PATIENTS WITH MILD TO MODERATE DEPRESSION: INEFFECTIVENESS OF ANTIDEPRESSIVE THERAPY WITH PIRLINDOL IN RANDOMIZED STUDY
Aim. To evaluate the influence of antidepressant therapy with pirlindol on compliance to the long-term treatment and quality of life in patients with cardiovascular diseases and mild to moderate depression. Material and methods. 61 patients with cardiovascular diseases and mild to moderate depression (according to Beck depression scale) were randomized into two groups. Patients of intervention group received pirlindol, while patients of control group did not receive this drug. Compliance to cardiovascular and antidepressant treatment were estimated in 3 and 6 months. Adverse reactions and patients self-assessment of their well-being and global satisfaction in treatmen were also registered. Results. 24 (75%), 2 (6%) and 0 patients of intervention group continue pirlindol treatment in 1, 3 and 6 months, respectively. In 3 months of observation patients of intervention group took drugs for cardiovascular diseases more often than these in control group (81% vs 72%, respectively , р<0.05), they also less frequently showed adverse reactions (56% vs 72%, respectively ,p=0.01) and more often — improvement of their well-being (65% vs 50%, respectively , р=0.03). Compliance to cardiovascular therapy did not differ significantly in patients of both groups by the end the study. Conclusion. Antidepressant therapy with pirlindol did not influence compliance to long-term cardiovascular treatment in patients with cardiovascular diseases and mild to moderate depression, apparently because of low compliance to pirlindol therapy.
- 1 January 2007
- No. 9,p. 6-10
[Periodic medical examinations: problem of concordance].
From bioethics and contemporary medical legislation viewpoints, the authors consider a topic of periodic medical examinations and possibility of concordance between doctor and patient. Opinion is that in order to gain concordance and higher efficiency of the examinations, the doctor should separate occupational examination function from medical function.
- 1 January 2007
- No. 9,p. 6-10
[Periodic medical examinations: problem of concordance].
From bioethics and contemporary medical legislation viewpoints, the authors consider a topic of periodic medical examinations and possibility of concordance between doctor and patient. Opinion is that in order to gain concordance and higher efficiency of the examinations, the doctor should separate occupational examination function from medical function.